Portola Pharmaceuticals, Inc. Net Profit Margin 2013-2020 | PTLA
Portola Pharmaceuticals, Inc. net profit margin from 2013 to 2020. Net profit margin can be defined as net Income as a portion of total sales revenue.
| Net Profit Margin Historical Data | |||
|---|---|---|---|
| Date | TTM Revenue | TTM Net Income | Net Margin |
| 2020-03-31 | $0.12B | $-0.28B | -235.00% |
| 2019-12-31 | $0.12B | $-0.29B | -250.86% |
| 2019-09-30 | $0.10B | $-0.28B | -277.45% |
| 2019-06-30 | $0.08B | $-0.30B | -384.81% |
| 2019-03-31 | $0.06B | $-0.34B | -625.45% |
| 2018-12-31 | $0.04B | $-0.35B | -875.00% |
| 2018-09-30 | $0.04B | $-0.35B | -1008.57% |
| 2018-06-30 | $0.03B | $-0.37B | -1460.00% |
| 2018-03-31 | $0.03B | $-0.33B | -1316.00% |
| 2017-12-31 | $0.02B | $-0.29B | -1247.83% |
| 2017-09-30 | $0.03B | $-0.25B | -922.22% |
| 2017-06-30 | $0.03B | $-0.26B | -809.38% |
| 2017-03-31 | $0.03B | $-0.25B | -768.75% |
| 2016-12-31 | $0.04B | $-0.27B | -768.57% |
| 2016-09-30 | $0.03B | $-0.28B | -1124.00% |
| 2016-06-30 | $0.02B | $-0.24B | -1278.95% |
| 2016-03-31 | $0.02B | $-0.24B | -1435.29% |
| 2015-12-31 | $0.01B | $-0.23B | -2054.55% |
| 2015-09-30 | $0.01B | $-0.20B | -2211.11% |
| 2015-06-30 | $0.01B | $-0.18B | -2250.00% |
| 2015-03-31 | $0.01B | $-0.15B | -1912.50% |
| 2014-12-31 | $0.01B | $-0.14B | -1712.50% |
| 2014-09-30 | $0.01B | $-0.12B | -1537.50% |
| 2014-06-30 | $0.01B | $-0.11B | -1177.78% |
| 2014-03-31 | $0.01B | $-0.10B | -970.00% |
| 2013-12-31 | $0.01B | $-0.08B | -763.64% |
| 2013-09-30 | $0.01B | $-0.07B | -700.00% |
| 2013-06-30 | $0.07B | $-0.05B | -66.22% |
